Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observational real world study describing characteristics of patients prescribed Evolocumab in Europe.

Next Previous
Trial Profile

An observational real world study describing characteristics of patients prescribed Evolocumab in Europe.

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Evolocumab (Primary)
  • Indications Cardiovascular disorders; Hypercholesterolaemia
  • Focus Therapeutic Use

    • Most Recent Events

    • 01 Sep 2020 Results (n=779 of analysis predicting baseline CV risk and assessing potential risk reduction among a large European cohort of evolocumab users using interim data presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
    • 19 Sep 2018 New trial record
    • 29 Aug 2018 Interim results (n=476) presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top